Prolonged hyperoxia preconditioning attenuates behavioral symptoms of 6-hydroxydopamine-induced Parkinsonism

Neurological Research

Volumn 34, Issue 7, 2012, Pages 636-642

  Hamidi, Gholam Ali ^a   Faraji, Ayda ^b   Zarmehri, Hassan Azhdari ^b   Haghdoost Yazdi, Hashem ^b  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

6 OHDA; Behavioral symptoms; Intermittent; Parkinson's disease; Prolonged hyperoxia preconditioning

Indexed keywords

APOMORPHINE; OXIDOPAMINE;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE SEVERITY; HYPEROXIA; MALE; MOTOR PERFORMANCE; NONHUMAN; OXYGEN CONCENTRATION; PARKINSONISM; PROLONGED HYPEROXIA PRECONDITIONING; RAT; STEREOTAXIC SURGERY; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BEHAVIORAL SYMPTOMS; HYPEROXIA; ISCHEMIC PRECONDITIONING; MALE; OXIDOPAMINE; PARKINSONIAN DISORDERS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84865118338     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000056     Document Type: Article

References (25)

1. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909.
2. Cadet JL, Krasnova IN. Cellular and molecular neurobiology of brain preconditioning. Mol Neurobiol. 2009;39:50-61.
3. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol. 2009;104:189-202.
4. Tanaka H, Calderone A, Jover T, Grooms SY, Yokota H, Zukin RS, et al. Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1. Proc Natl Acad Sci USA. 2002;99:2362-7.
5. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009;8:398-412.
6. Soane L, Kahraman S, Kristian T, Fiskum G. Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders. J Neurosci Res. 2007;85:3407-15.
7. Sano T, Izuishi K, Hossain MA, Kakinoki K, Okano K, Masaki T, et al. Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury. HPB (Oxford). 2010;12:538-45.
8. Toyoda T, Kassell NF, Lee KS. Induction of ischemic tolerance and antioxidant activity by brief focal ischemia. Neuroreport. 1997;8:847-51.
9. Riepe MW, Ludolph AC. Chemical preconditioning: a cytoprotective strategy. Mol Cell Biochem. 1997;174:249-54.
10. Bigdeli MR. Preconditioning with prolongeded normobaric hyperoxia induces ischemic tolerance partly by upregulation of antioxidant enzymes in rat brain tissue. Brain Res. 2009;1260:47-54.
11. Prass K, Wiegand F, Schumann P, Ahrens M, Kapinya K, Harms C, et al. Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent. Brain Res. 2000;871:146-50.
12. Wang L, Li W, Kang Z, Liu Y, Deng X, Tao H, et al. Hyperbaric oxygen preconditioning attenuates early apoptosis after spinal cord ischemia in rats. J Neurotrauma. 2009;26:55-66.
13. Shimohama S, Sawada H, Kitamura Y, Taniguchi T. Disease model: Parkinson's disease. Trends Mol Med. 2003;9:360-5.
14. Iancu R, Mohapel P, Brundin P, Paul G. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res. 2005;162:1-10.
15. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
16. Belmadani A, Kumar S, Schipma M, Collins MA, Neafsey EJ. Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport. 2004;15:2093-6.
17. Xu YF, Zhang YJ, Zhang AH, Zhang Q, Wu T, Wang JZ. Attenuation of okadaic acid-induced hyperphosphorylation of cytoskeletal proteins by heat preconditioning and its possible underlying mechanisms. Cell Stress Chaperones. 2004;9:304-12.
18. Cannona JR, Keep RF, Schallert T, Hua Y, Richardson RJ, Xi G. Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease. Brain Res. 2006;1116:177-86.
19. Wada K, Miyazawa T, Nomura N, Yano A, Tsuzuki N, Nawashiro H, et al. Mn-SOD and Bcl-2 expression after repeated hyperbaric oxygenation. Acta Neurochir Suppl. 2000;76:285-90.
20. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab. 2006;26:666-74.
21. Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T. Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology. 2002;96:907-12.
22. Botella JA, Bayersdorfer F, Schneuwly S. Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease. Neurobiol Dis. 2008;30:65-73.
23. D'Agostino DP, Colomb DG, Dean JB. Effects of hyperbaric gases on membrane nanostructure and function in neurons. J Appl Physiol. 2009;106:996-1003.
24. Tong L, Toliver-Kinsky T, Rassin D, Werrbach-Perez K, Perez-Polo JR. Hyperoxia increases AP-1 DNA binding in rat brain. Neurochem Res. 2003;28:111-5.
25. Wang YC, Zhang S, Du TY,Wang B, Sun XQ. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by stimulating autophagy in neurocyte. Brain Res. 2010;1323:149-51.